AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Psychiatrictimes

Published November 14, 2026

News | Page 18 - Psychiatric Times

Read the full story at Psychiatrictimes

psychedelic . Psychedelics : Powerful Tools for Burdensome Disorders. ByGuy Goodwin, MD. February 18th 2026. How are MDMA and psilocybin reshaping PTSD.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics